MedTrace Logo

Evaluation of Acclimate Feature for Positive Airway Pressure (PAP) Therapy

NCT01421654 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-03-12

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate if using the Acclimate feature at the beginning of Positive Airway Pressure (PAP) therapy results in patients using their PAP therapy at least as long as they would standard therapy. Additionally, the Acclimate feature will be evaluated with regard to patient comfort, ease of acceptance of PAP therapy, leak events, and respiratory events.

Conditions

Interventions

DEVICE

S9 Elite with Acclimate

S9 Elite Flow Generator with Acclimate feature activated

DEVICE

S9 Elite

S9 Elite Flow Generator

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Ken Plotkin, MD · Sleep Insights

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01421654 on ClinicalTrials.gov